Respiratory Diseases' Resources

Midwest Allergy Sinus Asthma, SC

Coming soon!

Related Articles:

Understanding the New RSV Vaccine for Adults and Pregnant Women

The new RSV vaccine, AREXVY, is designed to protect adults aged 50 and older and pregnant women against Respiratory Syncytial Virus (RSV), a virus responsible for severe respiratory infections. Extensively tested for safety and efficacy, the vaccine has shown to reduce the risk of RSV-associated lower respiratory tract infections by 82.6% in clinical trials. Vaccination not only protects the individual but also aids in community immunity, especially safeguarding vulnerable populations.

read more
Diagnosed with COPD or Chronic Bronchitis?

Diagnosed with COPD or Chronic Bronchitis?

This commercial is for a clinical research trial for those diagnosed with COPD or Chronic Bronchitis. For more information about current trials, visit our SWIA research tab or call us at 309-452-0995 to ask about our clinical research opportunities.

read more